Your browser doesn't support javascript.
loading
Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis.
Ehmann, Lisa; Zoller, Michael; Minichmayr, Iris K; Scharf, Christina; Huisinga, Wilhelm; Zander, Johannes; Kloft, Charlotte.
Afiliación
  • Ehmann L; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Kelchstr. 31, 12169 Berlin, Germany; Graduate Research Training Program PharMetrX.
  • Zoller M; Department of Anaesthesiology, Hospital of the Ludwig-Maximilians-Universität München, Munich, Germany.
  • Minichmayr IK; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Kelchstr. 31, 12169 Berlin, Germany; Graduate Research Training Program PharMetrX.
  • Scharf C; Department of Anaesthesiology, Hospital of the Ludwig-Maximilians-Universität München, Munich, Germany.
  • Huisinga W; Institute of Mathematics, Universität Potsdam, Potsdam, Germany.
  • Zander J; Institute of Laboratory Medicine, Hospital of the Ludwig-Maximilians-Universität München, Munich, Germany.
  • Kloft C; Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universität Berlin, Kelchstr. 31, 12169 Berlin, Germany. Electronic address: charlotte.kloft@fu-berlin.de.
Int J Antimicrob Agents ; 54(3): 309-317, 2019 Sep.
Article en En | MEDLINE | ID: mdl-31229669
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Bacterianas / Enfermedad Crítica / Meropenem / Antibacterianos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Antimicrob Agents Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones Bacterianas / Enfermedad Crítica / Meropenem / Antibacterianos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Antimicrob Agents Año: 2019 Tipo del documento: Article